NATIONAL CANCER CENTER HOSPITAL EAST
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1962-01-01
- Employees
- -
- Market Cap
- -
Lunit Presents 12 AI-Powered Studies at ASCO 2025, Demonstrating Enhanced Cancer Treatment Selection
Lunit will present 12 studies at ASCO 2025 showcasing AI-powered digital pathology solutions for precision oncology applications.
Lonsurf Shows Promising Survival Benefits for Stage 4 Colorectal Cancer Patients with Molecular Residual Disease
Phase 3 ALTAIR study reveals Lonsurf (trifluridine/tipiracil) significantly extended disease-free survival to 9.76 months versus 3.96 months with placebo in stage 4 colorectal cancer patients.
© Copyright 2025. All Rights Reserved by MedPath